---
title: "Fu Pengbo's latest heavy holdings revealed"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/248970531.md"
description: "On July 17th, Ruifeng Fund disclosed its Q2 2025 report, revealing that the Hong Kong stock position of the Ruifeng Growth Value Fund managed by Fu Pengbo and Zhu Lin increased from 25.97% to 27.35%. Eoptolink became one of the top ten heavy positions, with increased holdings in LUXSHARE-ICT, Cambricon, and GreatStar, while reducing holdings in Shenghong Technology and Tencent Holdings. The Q2 report shows that the fund focuses on allocating resources to the electronics, internet technology, precision manufacturing, and pharmaceutical sectors, with significant gains in the PCB industry chain stocks and an increase in allocation to the pharmaceutical sector"
datetime: "2025-07-17T12:06:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/248970531.md)
  - [en](https://longbridge.com/en/news/248970531.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/248970531.md)
---

# Fu Pengbo's latest heavy holdings revealed

On July 17th, the public fund products under Ruiyuan Fund disclosed their Q2 2025 report. In the second quarter of this year, the Hong Kong stock position of Ruiyuan Growth Value, managed by renowned fund managers Fu Pengbo and Zhu Lin, increased from 25.97% to 27.35%. In terms of specific holdings, Eoptolink entered the top ten heavy stocks of this fund, in addition, the fund increased its holdings in LUXSHARE-ICT, Cambricon, and GreatStar, while reducing its holdings in Shenghong Technology, Tencent Holdings, CATL, China Mobile, Sanofi, and Maiwei Co., Ltd. Fu Pengbo and Zhu Lin stated in the Q2 report that the net value contribution of the Hong Kong stock targets and PCB targets of the fund was significant in the second quarter, with an overall allocation focused on electronics, internet technology, precision manufacturing, and pharmaceuticals. Compared to the first quarter, the stocks in the PCB industry chain among the top ten holdings saw significant increases, and their proportion increased significantly. In addition, the fund also increased its allocation in the pharmaceutical sector, involving sub-industries such as innovative drugs and traditional medicine benefiting from AI

### Related Stocks

- [002444.CN](https://longbridge.com/en/quote/002444.CN.md)
- [300502.CN](https://longbridge.com/en/quote/300502.CN.md)
- [002475.CN](https://longbridge.com/en/quote/002475.CN.md)
- [688256.CN](https://longbridge.com/en/quote/688256.CN.md)

## Related News & Research

- [Hisense Home Appliances Deploys RMB1.81 Billion into Chongqing Trust Wealth Products](https://longbridge.com/en/news/286888326.md)
- [Strix Discloses Trust-Led Share Tender by Non-Executive Director](https://longbridge.com/en/news/286884952.md)
- [Singapore accounts for 25% of password stealer detections in Southeast Asia](https://longbridge.com/en/news/287000672.md)
- [Indonesia’s investment app Pluang raises $10M, expands into equities marketGrows**](https://longbridge.com/en/news/286855201.md)
- [11:08 ETPix Media Launches Pix Plus Premium Newsletter Bundle](https://longbridge.com/en/news/286937267.md)